ACTON, Mass. --(BUSINESS WIRE)--Nov. 24, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the virtual 45 th Nasdaq Investor Conference on Friday,
ACTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2021 .
ACTON, Mass. --(BUSINESS WIRE)--Nov. 1, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced various activities to recognize Diabetes Awareness Month and World Diabetes Day
ACTON, Mass. --(BUSINESS WIRE)--Oct. 18, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Luciana Borio , M.D., has been appointed to the Company’s Board of Directors.
ACTON, Mass. --(BUSINESS WIRE)--Sep. 30, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has presented positive pivotal trial extension phase results for the Omnipod® 5 Automated Insulin
ACTON, Mass. --(BUSINESS WIRE)--Sep. 29, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the third quarter of 2021 on November
ACTON, Mass. --(BUSINESS WIRE)--Aug. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at three upcoming virtual investor conferences: The 2021 Virtual
ACTON, Mass. --(BUSINESS WIRE)--Aug. 16, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced FDA clearance for use of Eli Lilly and Company’s (NYSE: LLY) Lyumjev ® (insulin
ACTON, Mass. --(BUSINESS WIRE)--Aug. 11, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented the Omnipod DASH® Insulin Management System (Omnipod DASH) to healthcare providers
ACTON, Mass. --(BUSINESS WIRE)--Aug. 5, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended June 30, 2021 .
ACTON, Mass. --(BUSINESS WIRE)--Jul. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming virtual investor conferences: The Canaccord 41 st
ACTON, Mass. --(BUSINESS WIRE)--Jul. 1, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the second quarter of 2021 on August 5,
ACTON, Mass. --(BUSINESS WIRE)--Jun. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced promising results from its latest pivotal trial for the Omnipod 5 Automated
ACTON, Mass. --(BUSINESS WIRE)--Jun. 24, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its schedule of events for the American Diabetes Association (ADA) Virtual 81 st
ACTON, Mass. --(BUSINESS WIRE)--May 6, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2021 .
